159 related articles for article (PubMed ID: 36165427)
21. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
22. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
23. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
[TBL] [Abstract][Full Text] [Related]
24. The expression and function of long noncoding RNA lncRNA-ATB in papillary thyroid cancer.
Fu XM; Guo W; Li N; Liu HZ; Liu J; Qiu SQ; Zhang Q; Wang LC; Li F; Li CL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3239-3246. PubMed ID: 28770959
[TBL] [Abstract][Full Text] [Related]
25. [Expression and clinical significance of Nrf2 and ERK pathway in papillary thyroid carcinoma].
Chen YM; Wei L; Lin X; Zhang WJ; Wu JF; Xue G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(12):941-945. PubMed ID: 29798417
[No Abstract] [Full Text] [Related]
26. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
27. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
[TBL] [Abstract][Full Text] [Related]
28. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
Chen X; Jin J; Zheng L; Sheng Y; Sun J
J BUON; 2021; 26(1):259-265. PubMed ID: 33721460
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis.
Zhao J; Zhang Y; Zheng X
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):635-638. PubMed ID: 35210104
[TBL] [Abstract][Full Text] [Related]
32. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
Yue C; Zhao X; Tian C; Jin Y; Liu H
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):490-4. PubMed ID: 26705040
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H
Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D
Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
[TBL] [Abstract][Full Text] [Related]
35. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
36. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
37. Role of laminin 332 in lymph node metastasis of papillary thyroid carcinoma.
Oh KH; Choi J; Woo JS; Baek SK; Jung KY; Koh MJ; Kim YS; Kwon SY
Auris Nasus Larynx; 2017 Dec; 44(6):729-734. PubMed ID: 28238469
[TBL] [Abstract][Full Text] [Related]
38. Beclin 1 is highly expressed in papillary thyroid carcinoma and correlates with lymph node metastasis.
Li X; Xu H; Ma H
Acta Chir Belg; 2013; 113(3):175-81. PubMed ID: 24941712
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
40. [Expression of microRNA-155 in papillary thyroid carcinoma and its clinical significance].
Zhu YZ; Zheng K; Zhang HH; Chen L; Wu KL; Ren CH; Wang ZC; Kong LJ; Ruan WH; Chen XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1364-1368. PubMed ID: 27777199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
